Precision medicine: The personal touch

As we move away from a ‘one-size-fits-all’ approach to medicine, we move towards the future: precision medicine.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Biotechnology

Pfizer strikes $10.5 billion oncology deal with Chinese biotech

4 June 2026 The deal gives Pfizer access to 12 early-stage oncology programmes and marks the latest in a growing wave of high-value licensing agreements between Big Pharma and Chinese biotechs.

Biotechnology

Gilead to pay up to $5bn for antibody-drug conjugates push

8 April 2026 The acquisition of Munich-based biotech gives Gilead ownership of proprietary ADCs tech at a time when pharma and biotech companies are racing to secure next-generation cancer treatments.

Biotechnology

Closing the women's health gap offers ‘benefits for all’

7 April 2026 On World Health Day 2026, despite data trending in the right direction, systemic barriers continue to limit female inventors—and women's health is suffering.

More features

Siemens ordered to recall mammography device across European countries

US biotech fires trade secrets suit at Chinese pharma group

Pfizer strikes $10.5 billion oncology deal with Chinese biotech

Heated LNP litigation puts Moderna and Acuitas in the spotlight

J&J unit's valuable heart pump saved by 'rare' patent defence

Federal Circuit tosses $59m trade secrets judgment against EOFlow

Chinese medtech company fined by UPC over injunction breaches

Kirkland & Ellis subject of alleged conflict in trade secrets clash

Precision medicine: The personal touch

More on this story

Editor's picks

Editor's picks

More features